Patents Assigned to Absynth Biologics Limited
-
Patent number: 9610341Abstract: The disclosure relates to a composition comprising one, two or more immunogenic bacterial polypeptides and multivalent and monovalent vaccine compositions comprising the immunogenic bacterial polypeptides.Type: GrantFiled: April 9, 2013Date of Patent: April 4, 2017Assignee: Absynth Biologics LimitedInventors: Jorge Garcia Lara, Simon Foster
-
Patent number: 9233150Abstract: The disclosure relates to a composition comprising two or more immunogenic staphylococcal polypeptides and a multivalent vaccine composition comprising the immunogenic staphylococcal polypeptides.Type: GrantFiled: April 11, 2012Date of Patent: January 12, 2016Assignee: Absynth Biologics LimitedInventors: Jorge Garcia Lara, Simon Foster
-
Patent number: 9067980Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: GrantFiled: December 10, 2013Date of Patent: June 30, 2015Assignee: Absynth Biologics LimitedInventors: Simon J. Foster, Jorge Garcia-Lara
-
Publication number: 20140161835Abstract: The invention relates to an antigenic polypeptide referred to as DivIB and variants thereof, vaccines and immunogenic compositions comprising said polypeptide and the use of the vaccines and/or immunogenic compositions in the treatment and prevention of microbial infections.Type: ApplicationFiled: February 6, 2014Publication date: June 12, 2014Applicant: ABSYNTH BIOLOGICS LIMITEDInventors: Jorge GARCIA LARA, Simon FOSTER
-
Publication number: 20140099314Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: ApplicationFiled: December 10, 2013Publication date: April 10, 2014Applicant: ABSYNTH BIOLOGICS LIMITEDInventors: Simon J. FOSTER, Jorge GARCIA-LARA
-
Patent number: 8691242Abstract: The invention relates to an antigenic polypeptide referred to as DivlB and variants thereof, vaccines comprising said polypeptide and the use of the vaccine in protecting subjects from microbial infection.Type: GrantFiled: September 13, 2010Date of Patent: April 8, 2014Assignee: Absynth Biologics LimitedInventors: Jorge Garcia Lara, Simon Foster
-
Publication number: 20140044747Abstract: The disclosure relates to a composition comprising two or more immunogenic staphylococcal polypeptides and a multivalent vaccine composition comprising the immunogenic staphylococcal polypeptides.Type: ApplicationFiled: April 11, 2012Publication date: February 13, 2014Applicant: ABSYNTH BIOLOGICS LIMITEDInventors: Jorge Garcia Lara, Simon Foster
-
Patent number: 8632779Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: GrantFiled: March 14, 2012Date of Patent: January 21, 2014Assignee: Absynth Biologics LimitedInventors: Simon J. Foster, Jorge Garcia-Lara
-
Publication number: 20120195920Abstract: The invention relates to an antigenic polypeptide referred to as DivlB and variants thereof, vaccines comprising said polypeptide and the use of the vaccine in protecting subjects from microbial infection.Type: ApplicationFiled: September 13, 2010Publication date: August 2, 2012Applicant: ABSYNTH BIOLOGICS LIMITEDInventors: Jorge Garcia Lara, Simon Foster
-
Publication number: 20120171214Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: ApplicationFiled: March 14, 2012Publication date: July 5, 2012Applicant: ABSYNTH BIOLOGICS LIMITEDInventors: Simon J. FOSTER, Jorge GARCIA-LARA
-
Patent number: 8163288Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: GrantFiled: June 29, 2010Date of Patent: April 24, 2012Assignee: Absynth Biologics LimitedInventors: Simon J. Foster, Jorge Garcia-Lara
-
Publication number: 20110091465Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: ApplicationFiled: June 29, 2010Publication date: April 21, 2011Applicant: ABSYNTH BIOLOGICS LIMITEDInventors: Simon J. FOSTER, Jorge GARCIA-LARA
-
Publication number: 20080311108Abstract: The invention relates to antigenic polypeptides expressed by pathogenic microbes, vaccines comprising said polypeptides; therapeutic antibodies directed to said polypeptides and methods to manufacture said polypeptides, vaccines and antibodies.Type: ApplicationFiled: March 8, 2006Publication date: December 18, 2008Applicant: ABSYNTH BIOLOGICS LIMITEDInventors: Simon J. Foster, Jorge Garcia-Lara